What Pharma Can Learn From Military Intelligence - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

What Pharma Can Learn From Military Intelligence

Former military intelligence officer Tony Page discusses what pharma can learn from early warning systems, decision cycles, and the discipline of intelligence

  • August 21, 2026

  • 6 min

Share

  • 1

    Tony Page transitioned from military intelligence to pharma, emphasizing the importance of structured intelligence approaches in product development.

  • 2

    Page highlights that intelligence processes must be proactive and organized to support organizational strategy and decision-making.

  • 3

    He stresses the need for companies to monitor their environment and anticipate potential obstacles during product development and launch.

  • 4

    Page notes that many pharma companies fail to integrate intelligence effectively into planning, leading to reactive rather than proactive strategies.

  • 5

    He warns that AI must be purpose-built for specific problems in pharma, rather than treated as a general productivity tool.

Original Source(s)

What Pharma Can Learn From Military Intelligence

  • August 21, 2026

Related Content

IDSA updates guidance for antimicrobial-resistant gram-negative infections

"Determining how best to place and use these agents requires weighing multiple factors and is a constantly evolving science."

Correction: FcγRIIA signalling as a host-associated determinant of endosomal trafficking and antibody-dependent enhancement in flavivirus infection

Trends in urolithiasis mortality in the United States, 1999–2024: a Joinpoint regression analysis of age, sex, race, and regional disparities